Karyopharm Therapeutics Inc. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
Karyopharm Therapeutics Inc. (KPTI) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $49.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2021-11-03
- 2021-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $49.00K.
- 2021-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $117.00K.
- 2021-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $193.00K.
- 2020-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $327.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2021-09-30 | $49.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $117.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $193.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $327.00K 10-Q · filed 2021-11-03 |
| 2020-09-30 | $665.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $996.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $213.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $37.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $42.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $108.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $95.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $13.00K 10-K · filed 2020-02-26 |
| 2018-09-30 | $6.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $4.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | $10.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $15.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $29.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $39.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | $98.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $229.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $186.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $26.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $91.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $38.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $90.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $3.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |